Who owns AGILE THERAPEUTICS INC?
- Ticker: AGRX
- CUSIP Number: 00847l308
Tip: Access positions for across all investors
Analyze quarterly positions in Agile Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Agile Therapeutics stock
Who bought or sold AGILE THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 21k | $40k | 100% | Dec 2023 |
|
Citadel Advisors | 19k | $38k | 50% | Dec 2023 |
|
Jpmorgan Chase & Co | 7.7k | $15k | 122% | Dec 2023 |
|
Advisory Services Network | 2.0k | $3.9k | 100% | Dec 2023 |
|
Investor AB | 1.8k | $3.4k | 100% | Dec 2023 |
|
UBS Group | 1.4k | $2.7k | 100% | Dec 2023 |
|
Royal Bank of Canada | 798.00 | $2.0k | 214% | Dec 2023 |
|
Citigroup | 181.00 | $353.004300 | 0% | Dec 2023 |
|
Wells Fargo & Company | 19.00 | $37.000600 | 36% | Dec 2023 |
|
Advisor Group Holdings | 4.00 | $7.000000 | -20% | Dec 2023 |
|
Who sold out of Agile Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Cornerstone Planning Group | Sep 2023 | 10.00 | $24.000000 |